1,2-二氢-2-氧代-5-苯基-3-吡啶羧酸 | 10177-08-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 1,2-二氢-2-氧代-5-苯基-3-吡啶羧酸
• 英文名称: 1,2-dihydro-2-oxo-5-phenyl-3-pyridinecarboxylic acid
• 英文别名: 5-phenyl-2-pyridone-3-carboxylic acid；2-oxo-5-phenyl-1,2-dihydro-pyridine-3-carboxylic acid；5-Phenyl-1,2-dihydro-2-oxo-nicotinsaeure；2-oxo-5-phenyl-1H-pyridine-3-carboxylic acid
• CAS: 10177-08-9
• 化学式: C₁₂H₉NO₃
• 分子量: 215.208
• InChiKey: SIHMMTANWQXEHE-UHFFFAOYSA-N

物化性质

• 熔点：
  282 °C
• 沸点：
  469.9±45.0 °C(Predicted)
• 密度：
  1.362±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  66.4
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2933399090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

1,2-二氢-2-氧代-5-苯基-3-吡啶羧酸MSDS英文版

反应信息

• 作为反应物：
  描述：

  1,2-二氢-2-氧代-5-苯基-3-吡啶羧酸 在 苯膦酰二氯 、 氯化亚砜 、 sodium hydride 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 为溶剂， 反应 8.17h， 生成 2-(2-chloroethyl)-3,4-dihydro-4-methyl-7-phenylpyrido<3,2-f>-1,4-oxazepin-5(2H)-one
  参考文献：
  名称：

  Benzo- and pyrido-1,4-oxazepin-5-ones and -thiones: synthesis and structure-activity relationships of a new series of H1-antihistamines

  摘要：

  A series of novel benzo- and pyrido-1,4-oxazepinones and -thiones which represents a new structural class of compounds possessing H1 antihistaminic activity was synthesized, and the SARs were evaluated. The antihistaminic activity was determined by blockade of histamine-induced lethality in guinea pigs. The sedative potential was determined by comparison of the EEG profiles of the compounds with those of known sedating and nonsedating antihistamines. Several of the compounds were shown to possess potent H1 antihistaminic activity and to be free of the cortical slowing with synchronized waves and spindling activity found in the EEG of sedative antihistamines. One compound, 2-[2-(dimethylamino)ethyl]-3,4-dihydro-4-methylpyrido[3,2-f]-1,4- oxazepine-5(2H)-thione (rocastine) is currently undergoing clinical evaluation as a nonsedating H1 antihistamine.

  DOI：

  10.1021/jm00129a026
• 作为产物：
  描述：

  1,2-二氢-2-氧代-5-苯基-3-吡啶甲腈 以 sodium hydroxide 、 硫酸 为溶剂， 生成 1,2-二氢-2-氧代-5-苯基-3-吡啶羧酸
  参考文献：
  名称：

  Substituted 3-alkyl-6-phenyl-1,2,4-triazolo-[4,3-a]pyridines

  摘要：

  这份披露描述了作为抗焦虑药物有用的新型3-烷基-6-(取代苯基)-1,2,4-三唑并[4,3-a]吡啶。

  公开号：

  US04242515A1

文献信息

• Fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur
  申请人：A. H. Robins Company, Inc.

  公开号：US04705853A1

  公开（公告）日：1987-11-10

  Aromatic azepinones and thiones having the formula ##STR1## wherein; A is benzene, naphthalene, quinoline or pyridine; B is oxygen or sulfur; E is oxygen, sulfur or ##STR2## n is 1, 2 or 3; Z is an amino or a heterocyclic nitrogen-containing radical; R is hydrogen, loweralkyl, cycloalkyl or phenylloweralkyl; Y is halo, loweralkyl, loweralkoxy, diloweralkylamino, nitro, amino, loweracetylamino, trifluoromethyl, phenyl or phenyl substituted by one to three Y' radicals selected from halo, loweralkyl, loweralkoxy, diloweralkylamino, nitro, amino, loweracylamino or trifluoromethyl; and having antihistaminic utility, a process for the preparation thereof and chemical intermediates therefor are disclosed.

  芳香族氮杂七元酮和硫醚的化学式为##STR1##其中；A为苯、萘、喹啉或吡啶；B为氧或硫；E为氧、硫或##STR2##n为1、2或3；Z为氨基或含氮杂环的基团；R为氢、较低烷基、环烷基或苯基较低烷基；Y为卤素、较低烷基、较低烷氧基、二较低烷基氨基、硝基、氨基、较低乙酰氨基、三氟甲基、苯基或被从卤素、较低烷基、较低烷氧基、二较低烷基氨基、硝基、氨基、较低酰胺基或三氟甲基中选择的一个至三个Y'基团取代的苯基；具有抗组胺作用，公开了其制备方法和化学中间体。
• Substituted 3-alkyl-6-phenyl-1,2,4-triazolo-[4,3-a]pyridines
  申请人：American Cyanamid Company

  公开号：US04242515A1

  公开（公告）日：1980-12-30

  This disclosure describes novel 3-alkyl-6-(substituted-phenyl)-1,2,4-triazolo[4,3-a]pyridines useful as anxiolytic agents.

  这份披露描述了作为抗焦虑药物有用的新型3-烷基-6-(取代苯基)-1,2,4-三唑并[4,3-a]吡啶。
• Fused heterocyclic kinase inhibitors
  申请人：Borzilleri M. Robert

  公开号：US20050288290A1

  公开（公告）日：2005-12-29

  In general, the instant invention comprises compounds of Formulas I and II including pharmaceutically acceptable salts thereof. The compounds of the invention are useful as protein kinase inhibitors and therefore are useful for treating cancer and other protein kinase mediated diseases.

  一般而言，本发明涉及公式I和II的化合物，包括其药学上可接受的盐。本发明的化合物可用作蛋白激酶抑制剂，因此可用于治疗癌症和其他蛋白激酶介导的疾病。
• Pyrrolotriazine kinase inhibitors
  申请人：Borzilleri Robert M.

  公开号：US20060004006A1

  公开（公告）日：2006-01-05

  In general, the instant invention comprises compounds of Formulas I and II including pharmaceutically acceptable salts thereof. The compounds of the invention are useful as protein kinase inhibitors and therefore are useful for treating cancer and other protein kinase mediated diseases.

  一般而言，本发明涉及公式I和II的化合物及其药学上可接受的盐。本发明的化合物可用作蛋白激酶抑制剂，因此可用于治疗癌症和其他蛋白激酶介导的疾病。
• Pyridones useful as inhibitors of kinases
  申请人：Charrier Jean-Damien

  公开号：US20060183911A1

  公开（公告）日：2006-08-17

  The present invention relates to compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing the compounds of the invention and intermediate compounds useful in these processes.

  本发明涉及一种作为蛋白激酶抑制剂有用的化合物。本发明还提供了包含所述化合物的药学上可接受的组合物，以及使用这些组合物治疗各种疾病、状况或障碍的方法。本发明还提供了制备本发明化合物和在这些过程中有用的中间化合物的方法。